FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3048014675> ?p ?o ?g. }

• W3048014675 endingPage "e0237236" @default.
• W3048014675 startingPage "e0237236" @default.
• W3048014675 abstract "We previously reported that the non-immunosuppressive cyclophilin inhibitors (CypIs)—cyclosporin A analog CRV431 and sanglifehrin analog NV556—efficiently inhibit HCV replication in vitro. In this study, we asked whether they can also reduce HCV replication in vivo. We found that a single oral administration of CRV431 and NV556 to HCV-infected humanized-liver mice drastically reduced HCV blood levels. The antiviral effect was observed when CRV431 or NV556 were each individually administered with HCV, 3, 6 weeks or even 3 months post-infection when viral replication is robust. These results were confirmed in chimeric mice implanted with human hepatocytes isolated from three distinct donors. Remarkably, no viral rebound was observed 5 months after a single dose administration of 50 mg/kg of CRV431 or NV556 four weeks post-HCV infection, indicating the possibility of suppression of an established viral infection. Since we recently demonstrated that both CRV431 and NV556 also inhibit the development of liver fibrosis and hepatocellular carcinoma in nonviral-induced non-alcoholic steatohepatitis mouse models, our present data suggest that the two entirely structurally different CypIs—CRV431 and NV556—derived from unrelated natural products, represent attractive partners to current direct-acting agent (DAA) regimens for the treatment of hepatitis C and liver diseases." @default.
• W3048014675 created "2020-08-13" @default.
• W3048014675 creator A5006430479 @default.
• W3048014675 creator A5022208893 @default.
• W3048014675 creator A5049624262 @default.
• W3048014675 creator A5060217430 @default.
• W3048014675 creator A5079724107 @default.
• W3048014675 creator A5088967566 @default.
• W3048014675 date "2020-08-07" @default.
• W3048014675 modified "2023-09-30" @default.
• W3048014675 title "Structurally distinct cyclosporin and sanglifehrin analogs CRV431 and NV556 suppress established HCV infection in humanized-liver mice" @default.
• W3048014675 cites W1482367278 @default.
• W3048014675 cites W1783207458 @default.
• W3048014675 cites W1791855926 @default.
• W3048014675 cites W1801903034 @default.
• W3048014675 cites W1910369078 @default.
• W3048014675 cites W1977484015 @default.
• W3048014675 cites W2000676831 @default.
• W3048014675 cites W2002008013 @default.
• W3048014675 cites W2010470025 @default.
• W3048014675 cites W2020597127 @default.
• W3048014675 cites W2021722976 @default.
• W3048014675 cites W2042063943 @default.
• W3048014675 cites W2043958420 @default.
• W3048014675 cites W2050932098 @default.
• W3048014675 cites W2071959972 @default.
• W3048014675 cites W2076811542 @default.
• W3048014675 cites W2095124892 @default.
• W3048014675 cites W2103368826 @default.
• W3048014675 cites W2106478851 @default.
• W3048014675 cites W2107720148 @default.
• W3048014675 cites W2122523052 @default.
• W3048014675 cites W2144290486 @default.
• W3048014675 cites W2351890395 @default.
• W3048014675 cites W2883830132 @default.
• W3048014675 cites W2896231494 @default.
• W3048014675 cites W2911067384 @default.
• W3048014675 cites W2951604497 @default.
• W3048014675 doi "https://doi.org/10.1371/journal.pone.0237236" @default.
• W3048014675 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7413547" @default.
• W3048014675 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32764799" @default.
• W3048014675 hasPublicationYear "2020" @default.
• W3048014675 type Work @default.
• W3048014675 sameAs 3048014675 @default.
• W3048014675 citedByCount "9" @default.
• W3048014675 countsByYear W30480146752020 @default.
• W3048014675 countsByYear W30480146752021 @default.
• W3048014675 countsByYear W30480146752022 @default.
• W3048014675 countsByYear W30480146752023 @default.
• W3048014675 crossrefType "journal-article" @default.
• W3048014675 hasAuthorship W3048014675A5006430479 @default.
• W3048014675 hasAuthorship W3048014675A5022208893 @default.
• W3048014675 hasAuthorship W3048014675A5049624262 @default.
• W3048014675 hasAuthorship W3048014675A5060217430 @default.
• W3048014675 hasAuthorship W3048014675A5079724107 @default.
• W3048014675 hasAuthorship W3048014675A5088967566 @default.
• W3048014675 hasBestOaLocation W30480146751 @default.
• W3048014675 hasConcept C126322002 @default.
• W3048014675 hasConcept C140704245 @default.
• W3048014675 hasConcept C150903083 @default.
• W3048014675 hasConcept C159047783 @default.
• W3048014675 hasConcept C203014093 @default.
• W3048014675 hasConcept C207001950 @default.
• W3048014675 hasConcept C2522874641 @default.
• W3048014675 hasConcept C2776156784 @default.
• W3048014675 hasConcept C2776408679 @default.
• W3048014675 hasConcept C2776455275 @default.
• W3048014675 hasConcept C2778019345 @default.
• W3048014675 hasConcept C2778772119 @default.
• W3048014675 hasConcept C2779134260 @default.
• W3048014675 hasConcept C2779478299 @default.
• W3048014675 hasConcept C2781463415 @default.
• W3048014675 hasConcept C502942594 @default.
• W3048014675 hasConcept C71924100 @default.
• W3048014675 hasConcept C86803240 @default.
• W3048014675 hasConcept C98274493 @default.
• W3048014675 hasConceptScore W3048014675C126322002 @default.
• W3048014675 hasConceptScore W3048014675C140704245 @default.
• W3048014675 hasConceptScore W3048014675C150903083 @default.
• W3048014675 hasConceptScore W3048014675C159047783 @default.
• W3048014675 hasConceptScore W3048014675C203014093 @default.
• W3048014675 hasConceptScore W3048014675C207001950 @default.
• W3048014675 hasConceptScore W3048014675C2522874641 @default.
• W3048014675 hasConceptScore W3048014675C2776156784 @default.
• W3048014675 hasConceptScore W3048014675C2776408679 @default.
• W3048014675 hasConceptScore W3048014675C2776455275 @default.
• W3048014675 hasConceptScore W3048014675C2778019345 @default.
• W3048014675 hasConceptScore W3048014675C2778772119 @default.
• W3048014675 hasConceptScore W3048014675C2779134260 @default.
• W3048014675 hasConceptScore W3048014675C2779478299 @default.
• W3048014675 hasConceptScore W3048014675C2781463415 @default.
• W3048014675 hasConceptScore W3048014675C502942594 @default.
• W3048014675 hasConceptScore W3048014675C71924100 @default.
• W3048014675 hasConceptScore W3048014675C86803240 @default.
• W3048014675 hasConceptScore W3048014675C98274493 @default.
• W3048014675 hasFunder F4320332161 @default.
• W3048014675 hasIssue "8" @default.
• W3048014675 hasLocation W30480146751 @default.

• next